z-logo
open-access-imgOpen Access
miR‑24 may be a negative regulator of menin in lung cancer
Author(s) -
Yunhu Pan,
Hongmei Wang,
Debin Ma,
Zhiyu Ji,
Limin Luo,
Fangyu Cao,
Fangfang Huang,
Yang Liu,
Yushu Dong,
Yitan Chen
Publication year - 2018
Publication title -
oncology reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.094
H-Index - 96
eISSN - 1791-2431
pISSN - 1021-335X
DOI - 10.3892/or.2018.6327
Subject(s) - lung cancer , oncogene , molecular medicine , microrna , cancer research , cell cycle , cancer , metastasis , regulator , suppressor , biology , apoptosis , carcinogenesis , targeted therapy , cell growth , treatment of lung cancer , oncology , medicine , gene , genetics
The incidence of lung cancer in China increases annually, and effective targets for the diagnosis and treatment of lung cancer are urgently needed. miRNAs are currently considered to be involved in the regulation of tumor development and growth. miR‑24 has been found to contribute to the development of several tumors. Menin is a key tumor suppressor gene, and its expression is generally low in lung cancer. The effects of miR‑24 on the biological behavior of lung cancer cells were detected by MTT and Transwell assays. In the present study, miR‑24 was found to be associated with menin, affecting the activity of the SMAD3 pathway in lung cancer by inhibiting menin expression. miR‑24 may promote the growth and metastasis and inhibit the apoptosis of lung cancer cells by targeting menin. Therefore, the aim of the present study was to provide a new theoretical basis for the targeted therapy of lung cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom